Investment
Features
FeesSafety
Academy
More
Pluang+

Thiogenesis advances TTI-0102 with new clinical trials for rare pediatric diseases, targeting 2027 data.

Company Fundamentals
21 Sep 2026
Newsfile Corp
View Source
Bullish
Thiogenesis advances TTI-0102 with new clinical trials for rare pediatric diseases, targeting 2027 data.

Thiogenesis Therapeutics announced shareholder approvals and updates on its lead drug candidate TTI-0102, aimed at treating serious pediatric diseases like nephropathic cystinosis and Leigh syndrome. The company plans to start clinical studies in late 2026, with topline results expected in early 2027. These developments follow FDA Rare Pediatric Disease designation and a recent funding round, positioning Thiogenesis to address significant unmet medical needs with a potentially simpler treatment regimen for cystinosis and a novel approach for Leigh syndrome. Investors can anticipate key clinical milestones in the coming months.

Thiogenesis Therapeutics' 2026 shareholder meeting and corporate update provide context for health sector trading on Pluang. As of Sep 21, 2026 13:41 WIB, among 92 priced health-sector US stocks, 49 rose and 41 fell. Notable movers include Teladoc Health Inc (TDOC) at USD 6.24 with a -2.95% change and a typical hold time of 39 days, Baxter International Inc (BAX) at USD 22.90 with a -2.68% change and a 72-day hold time, and Summit Therapeutics Inc (SMMT) at USD 18.29 with a +2.46% change and an 18-day hold time. The most notable figure is Summit Therapeutics' 2.46% price increase.

More News

Nevada Organic Phosphate extends phosphate mineralization strike to 3 km, advancing 2026 drilling program.

Nevada Organic Phosphate extends phosphate mineralization strike to 3 km, advancing 2026 drilling program.

Nevada Organic Phosphate Inc. has successfully extended the confirmed strike length of its Upper Phosphate Zone to over 3 kilometres through drilling, marking a significant milestone. The company has mobilized Falcon Drilling to continue its 2026 exp...

Market News
Bullish
4 hours ago
Chainlink (LINK) price rises 6.2% to $12.11, eyeing $13 resistance amid strategic reserve buying.

Chainlink (LINK) price rises 6.2% to $12.11, eyeing $13 resistance amid strategic reserve buying.

Chainlink's (LINK) price increased by about 6.2% to $12.11 after bouncing from support near $11, with technical analysis suggesting a completed five-wave rally that could lead to further gains toward $13 and possibly $15. The Chainlink strategic rese...

Technical Signals
Bullish
4 hours ago
Oil prices drop over 2% as Saudi exports recover and US-Iran talks loom

Oil prices drop over 2% as Saudi exports recover and US-Iran talks loom

Crude oil prices fell more than 2% following signs of recovering Saudi Arabian oil exports and potential renewed US-Iran diplomacy. BP and Shell shares declined in early trading as Brent crude dropped to $101.65 a barrel and WTI to $93.97. The market...

Market News
Bearish
4 hours ago
Cardano integrates with x402 SDK for direct ADA payments via API calls without accounts.

Cardano integrates with x402 SDK for direct ADA payments via API calls without accounts.

Cardano has integrated with the x402 SDK, enabling applications and AI agents to pay for API calls directly in ADA or Cardano-native tokens using standard HTTP requests without needing accounts or API keys. This integration leverages the HTTP 402 "Pa...

Protocol Fundamentals
Bullish
4 hours ago
Saudi oil exports rebound over 4M barrels/day despite Hormuz risks; natural gas tight amid LNG output limits.

Saudi oil exports rebound over 4M barrels/day despite Hormuz risks; natural gas tight amid LNG output limits.

Saudi Arabia has restored its oil exports to over 4 million barrels per day after pipeline damage, improving market balance despite low tanker traffic through the Strait of Hormuz. The use of shuttle tankers and ship-to-ship transfers near Oman has h...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App